Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer

JAMA. 2006 Dec 6;296(21):2558-60. doi: 10.1001/jama.296.21.2558-c.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Immunologic Factors / adverse effects*
  • Immunologic Factors / therapeutic use
  • Lenalidomide
  • Multiple Myeloma / drug therapy*
  • Neoplasms / drug therapy
  • Thalidomide / adverse effects*
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use
  • Thromboembolism / chemically induced*
  • Thromboembolism / epidemiology

Substances

  • Immunologic Factors
  • Thalidomide
  • Lenalidomide